Non-Invasive Liver Health Assessment
Fibroscan technology revolutionises liver disease diagnosis and monitoring by providing accurate, non-invasive assessment of liver fibrosis and stiffness. This painless procedure offers immediate results without the need for invasive liver biopsy in many cases.
Understanding Liver Fibrosis
Liver fibrosis develops when chronic inflammation leads to scarring of liver tissue. Early detection and monitoring of fibrosis progression are crucial for preventing advanced liver disease and cirrhosis.
The Fibroscan Procedure
Fibroscan uses transient elastography to measure liver stiffness, which correlates with the degree of fibrosis. The examination is performed by placing a probe on the skin over the liver, similar to routine ultrasound scanning.
Clinical Applications
Fibroscan is valuable for:
- Assessing fibrosis in hepatitis B and C
- Monitoring non-alcoholic fatty liver disease progression
- Evaluating treatment response in chronic liver disease
- Determining need for liver biopsy
- Long-term surveillance of liver health
Advantages
- Completely non-invasive and painless
- Immediate results available
- No radiation exposure
- Highly accurate for detecting significant fibrosis
- Cost-effective compared to liver biopsy
- Can be repeated safely for monitoring
Interpretation and Follow-up
Dr Chopdat’s expertise in liver disease ensures accurate interpretation of Fibroscan results within the context of your overall clinical picture. Results guide treatment decisions and monitoring strategies.
